NCT03114501

Brief Summary

Objectives: Primary Aim: Examine the feasibility of a dyadic yoga program in 40 Head and Neck Cancer (HNC) patients undergoing radiotherapy (RT) and their family caregivers. Secondary Aims: 1\. Establish the initial efficacy of the yoga program in patients and their caregivers regarding quality of life (QOL) outcomes (i.e., fatigue, sleep disturbance, depressive symptoms, and overall QOL) and objective performance outcomes (i.e, sit to stand test and grip strength).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
236

participants targeted

Target at P75+ for not_applicable

Timeline
12mo left

Started Apr 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Apr 2017Apr 2027

First Submitted

Initial submission to the registry

April 11, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

April 11, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 14, 2017

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2027

Last Updated

April 15, 2026

Status Verified

April 1, 2026

Enrollment Period

10.1 years

First QC Date

April 11, 2017

Last Update Submit

April 10, 2026

Conditions

Keywords

Malignant neoplasms of lip oral cavity and pharynxHead and Neck CancerYogaQuestionnairesSurveys

Outcome Measures

Primary Outcomes (1)

  • Feasibility of a Dyadic Yoga Program in Head and Neck Cancer (HNC) Participants Undergoing Radiotherapy (RT)

    Trial considered feasible if 1) ≥ 50% of eligible couples consent (i.e., approach 80 couples to obtain 40 consents); 2) ≥ 70% of enrolled couples complete both assessments; 3) on average ≥ 50% of all practice sessions are attended.

    6 weeks after radiation therapy

Secondary Outcomes (1)

  • Efficacy of a Dyadic Yoga Program in Head and Neck Cancer (HNC) Participants Undergoing Radiotherapy (RT)

    6 weeks after radiation therapy

Study Arms (2)

Yoga Program Group

EXPERIMENTAL

Participants take part in the partner-based yoga program. Questionnaire completed during each week of radiation therapy about participant's feelings about the yoga sessions. Questionnaires completed before first radiation treatment, during week 3 of radiation therapy, and again after completion of treatment schedule (usually 6 weeks later).

Behavioral: YogaBehavioral: Yoga QuestionnaireBehavioral: Symptom Questionnaires

Waitlist Control Group (WLC)

EXPERIMENTAL

Participants receive standard of care. Questionnaires completed before first radiation treatment, during week 3 of radiation therapy, and again after completion of treatment schedule (usually 6 weeks later). After the study has been completed, participant and caregiver/alternative caregiver offered the opportunity to take part in the partner-based yoga program.

Behavioral: Symptom Questionnaires

Interventions

YogaBEHAVIORAL

Participants receive yoga sessions up to 5 days per week, based on the patient's schedule, over the course of patients' Radiation Therapy (up to 15 sessions, 45-60 min. each). Yoga sessions audio and video recorded.

Yoga Program Group

Questionnaire completed during each week of radiation therapy about participant's feelings about the yoga sessions.

Also known as: Survey
Yoga Program Group

Symptom questionnaires completed before first radiation treatment, during week 3 of radiation therapy, and again after completion of treatment schedule (usually 6 weeks later).

Also known as: Surveys
Waitlist Control Group (WLC)Yoga Program Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • (Patients) Diagnosed with a primary HNC and going to receive at least 4 weeks of RT with at least 20 fractions
  • (Patients) ECOG performance status of 2 or lower
  • (Patients) having an informal family caregiver (spouse, romantic partner, adult child, or sibling) who is willing to participate. If patients do not have one consistent primary caregiver for the duration of the study, they may be accompanied to the yoga sessions by an alternate caregiver who meets eligibility criteria.
  • (Patients) having a smart phone (phase 2 only)
  • (Patients and Caregivers) must be (1) at least 18 years old
  • (Patients and Caregivers) able to read and speak English
  • (Patients and Caregivers) able to provide informed consent

You may not qualify if:

  • (Patients) regularly (self-defined) participated in a yoga practice in the year prior to diagnosis
  • (Patients) cognitive deficits that would impede the completion of self-report instruments as deemed by the clinical team
  • (Patients and Caregivers) those who participate in phase 1 are ineligible to participate in phase 2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Head and Neck Neoplasms

Interventions

YogaSurveys and Questionnaires

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesExercise Movement TechniquesPhysical Therapy ModalitiesData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Kathrin Milbury, MA,PHD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 11, 2017

First Posted

April 14, 2017

Study Start

April 11, 2017

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

April 30, 2027

Last Updated

April 15, 2026

Record last verified: 2026-04

Locations